Can Stem Cell-Delivered Platelets Fight Drug-Resistant Bacteria?- RPTH Journal
RPTH Journal shared a post on LinkedIn about a recent article by Qirui Lin et al:
“Can Stem Cell-Delivered Platelets Fight Drug-Resistant Bacteria?
MRSA infections remain a serious clinical challenge in the era of multidrug resistance.
Platelets are known to have antibacterial properties — but the mechanisms are incompletely understood, and whether induced pluripotent stem cell-derived platelets (iPSC-PLTs) share this capacity had never been tested.
A new study in RPTH Journal investigated the MRSA-killing potential of iPSC-PLTs and the mechanisms involved.
Key findings:
- All 3 iPSC-PLT clones demonstrated MRSA-killing capacity in vitro
- MyD88-deficient iPSC-PLTs showed impaired killing
- MRSA α-toxin (Hla) suppressed iPSC-PLT bactericidal function
iPSC-PLTs offer a unique advantage:
They are gene-editable, making them a powerful platform for investigating platelet antimicrobial function, and potentially a novel therapeutic tool against resistant infections.”
Title: Induced pluripotent stem cell-derived platelets kill multidrug-resistant Staphylococcus aureus via Toll-like receptor 2-MyD88 signaling and immunoglobulin G/FcyRIIA engagement
Authors: Qirui Lin, Kimiko Nonomura, Ieva Stirblyte, Sou Nakamura, Satoshi Uchiyama, Masaya Yamaguchi, Shigetada Kawabata, Miki Nagao, Katsue Suzuki-Inoue, Victor Nizet, Koji Eto, Naoshi Sugimoto
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 6, 2026, 17:39Kalyan Roy: Immunomodulation after Blood Transfusion
-
Jun 6, 2026, 17:37Intissar Haddiya: Can Low-Dose Rivaroxaban Improve Cardiovascular Outcomes in Patients with Advanced CKD?
-
Jun 6, 2026, 17:34Stanley Anokye: From Microcytes and Macrocytes to Target Cells
-
Jun 6, 2026, 16:53Leonardo Roever: Can a Simple Cholesterol Ratio Predict Post-Stroke Depression?
-
Jun 6, 2026, 16:21Abdulkader Jamal Eddin: ABO Blood Group, COVID-19 and Early Respiratory Outcomes in Acute PE
-
Jun 6, 2026, 15:26Yuying Zhang: Grateful to Present on CD44 as A Potential Plasma-Independent Alternative to IVIG in ITP
-
Jun 6, 2026, 15:16Don Deyo: Breakthrough Therapy for Post-Stroke Upper Limb Impairment Now Published
-
Jun 6, 2026, 15:14Julianne Chong: Components of Antithrombotic Stewardship Programs from an International Perspective
-
Jun 6, 2026, 15:13Vincent Ten Cate: The Largest Blood-Based EWAS of Atherosclerosis to Date